Consonance Capital Management as of Sept. 30, 2015
Portfolio Holdings for Consonance Capital Management
Consonance Capital Management holds 29 positions in its portfolio as reported in the September 2015 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Eagle Pharmaceuticals (EGRX) | 14.1 | $100M | 1.4M | 74.03 | |
| Insys Therapeutics | 13.0 | $93M | 3.3M | 28.46 | |
| Abbvie (ABBV) | 11.1 | $79M | 1.4M | 54.41 | |
| Retrophin | 9.8 | $70M | 3.5M | 20.26 | |
| Orthofix International Nv Com Stk | 8.5 | $60M | 1.8M | 33.75 | |
| Akorn | 7.5 | $53M | 1.9M | 28.50 | |
| Biosante Pharmaceuticals (ANIP) | 5.9 | $42M | 1.1M | 39.51 | |
| Osiris Therapeutics | 5.3 | $38M | 2.0M | 18.47 | |
| Cardiovascular Systems | 5.2 | $37M | 2.3M | 15.84 | |
| Pacific Biosciences of California (PACB) | 3.2 | $23M | 6.3M | 3.66 | |
| Enanta Pharmaceuticals (ENTA) | 2.9 | $21M | 571k | 36.14 | |
| Catalyst Pharmaceutical Partners (CPRX) | 2.5 | $17M | 5.8M | 3.00 | |
| Vanda Pharmaceuticals (VNDA) | 2.3 | $16M | 1.4M | 11.28 | |
| Epirus Biopharmaceuticals In | 1.4 | $10M | 2.3M | 4.42 | |
| Derma Sciences | 1.2 | $8.9M | 1.9M | 4.71 | |
| Adma Biologics (ADMA) | 1.2 | $8.8M | 1.1M | 8.36 | |
| Nanostring Technologies (NSTGQ) | 1.0 | $7.2M | 449k | 16.00 | |
| Vericel (VCEL) | 0.9 | $6.4M | 2.4M | 2.71 | |
| Clovis Oncology | 0.6 | $4.2M | 45k | 91.96 | |
| Seaspine Holdings | 0.6 | $4.0M | 249k | 16.20 | |
| Imprivata | 0.5 | $3.7M | 206k | 17.77 | |
| Merus Labs Intl | 0.2 | $1.7M | 1.3M | 1.29 | |
| BioTime | 0.2 | $1.6M | 540k | 3.00 | |
| Veracyte (VCYT) | 0.2 | $1.3M | 267k | 4.69 | |
| Biolase Technology | 0.1 | $1.0M | 1.2M | 0.90 | |
| Neothetics, Inc. Cmn | 0.1 | $987k | 122k | 8.07 | |
| Axogen (AXGN) | 0.1 | $925k | 224k | 4.12 | |
| Cti Biopharma | 0.1 | $672k | 460k | 1.46 | |
| Sientra | 0.1 | $606k | 60k | 10.16 |
